Global Viral Molecular Diagnostics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Viral Molecular Diagnostics market size was valued at US$ 7826 million in 2023. With growing demand in downstream market, the Viral Molecular Diagnostics is forecast to a readjusted size of US$ 12960 million by 2030 with a CAGR of 7.5% during review period.
The research report highlights the growth potential of the global Viral Molecular Diagnostics market. Viral Molecular Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Viral Molecular Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Viral Molecular Diagnostics market.
Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Viral Molecular Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Viral Molecular Diagnostics market. It may include historical data, market segmentation by Type (e.g., Hepatitis B Virus (HBV), Hepatitis C Virus (HCV)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Viral Molecular Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Viral Molecular Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Viral Molecular Diagnostics industry. This include advancements in Viral Molecular Diagnostics technology, Viral Molecular Diagnostics new entrants, Viral Molecular Diagnostics new investment, and other innovations that are shaping the future of Viral Molecular Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Viral Molecular Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Viral Molecular Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Viral Molecular Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Viral Molecular Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Viral Molecular Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Viral Molecular Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Viral Molecular Diagnostics market.
Market Segmentation:
Viral Molecular Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Viral Molecular Diagnostics market size was valued at US$ 7826 million in 2023. With growing demand in downstream market, the Viral Molecular Diagnostics is forecast to a readjusted size of US$ 12960 million by 2030 with a CAGR of 7.5% during review period.
The research report highlights the growth potential of the global Viral Molecular Diagnostics market. Viral Molecular Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Viral Molecular Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Viral Molecular Diagnostics market.
Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Viral Molecular Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Viral Molecular Diagnostics market. It may include historical data, market segmentation by Type (e.g., Hepatitis B Virus (HBV), Hepatitis C Virus (HCV)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Viral Molecular Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Viral Molecular Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Viral Molecular Diagnostics industry. This include advancements in Viral Molecular Diagnostics technology, Viral Molecular Diagnostics new entrants, Viral Molecular Diagnostics new investment, and other innovations that are shaping the future of Viral Molecular Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Viral Molecular Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Viral Molecular Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Viral Molecular Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Viral Molecular Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Viral Molecular Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Viral Molecular Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Viral Molecular Diagnostics market.
Market Segmentation:
Viral Molecular Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Human Immunodeficiency Virus (HIV)
- Human Papillomavirus (HPV)
- Hospitals
- Academics Institutions
- Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboraories
- Bio-Rad Laboratories
- Becton, Dickinson
- Roche
- Gen-Probe
- Qiagen
- Olympus
- Thermo Fisher Scientific
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Viral Molecular Diagnostics Market Size 2019-2030
2.1.2 Viral Molecular Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Viral Molecular Diagnostics Segment by Type
2.2.1 Hepatitis B Virus (HBV)
2.2.2 Hepatitis C Virus (HCV)
2.2.3 Human Immunodeficiency Virus (HIV)
2.2.4 Human Papillomavirus (HPV)
2.3 Viral Molecular Diagnostics Market Size by Type
2.3.1 Viral Molecular Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Viral Molecular Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Academics Institutions
2.4.3 Laboratories
2.4.4 Others
2.5 Viral Molecular Diagnostics Market Size by Application
2.5.1 Viral Molecular Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
3 VIRAL MOLECULAR DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Viral Molecular Diagnostics Market Size Market Share by Players
3.1.1 Global Viral Molecular Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Viral Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Viral Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VIRAL MOLECULAR DIAGNOSTICS BY REGIONS
4.1 Viral Molecular Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Viral Molecular Diagnostics Market Size Growth (2019-2024)
4.3 APAC Viral Molecular Diagnostics Market Size Growth (2019-2024)
4.4 Europe Viral Molecular Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Viral Molecular Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Viral Molecular Diagnostics Market Size by Country (2019-2024)
5.2 Americas Viral Molecular Diagnostics Market Size by Type (2019-2024)
5.3 Americas Viral Molecular Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Molecular Diagnostics Market Size by Region (2019-2024)
6.2 APAC Viral Molecular Diagnostics Market Size by Type (2019-2024)
6.3 APAC Viral Molecular Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Viral Molecular Diagnostics by Country (2019-2024)
7.2 Europe Viral Molecular Diagnostics Market Size by Type (2019-2024)
7.3 Europe Viral Molecular Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Viral Molecular Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Viral Molecular Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Viral Molecular Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VIRAL MOLECULAR DIAGNOSTICS MARKET FORECAST
10.1 Global Viral Molecular Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Viral Molecular Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Viral Molecular Diagnostics Forecast
10.1.3 APAC Viral Molecular Diagnostics Forecast
10.1.4 Europe Viral Molecular Diagnostics Forecast
10.1.5 Middle East & Africa Viral Molecular Diagnostics Forecast
10.2 Americas Viral Molecular Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Viral Molecular Diagnostics Market Forecast
10.2.2 Canada Viral Molecular Diagnostics Market Forecast
10.2.3 Mexico Viral Molecular Diagnostics Market Forecast
10.2.4 Brazil Viral Molecular Diagnostics Market Forecast
10.3 APAC Viral Molecular Diagnostics Forecast by Region (2025-2030)
10.3.1 China Viral Molecular Diagnostics Market Forecast
10.3.2 Japan Viral Molecular Diagnostics Market Forecast
10.3.3 Korea Viral Molecular Diagnostics Market Forecast
10.3.4 Southeast Asia Viral Molecular Diagnostics Market Forecast
10.3.5 India Viral Molecular Diagnostics Market Forecast
10.3.6 Australia Viral Molecular Diagnostics Market Forecast
10.4 Europe Viral Molecular Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Viral Molecular Diagnostics Market Forecast
10.4.2 France Viral Molecular Diagnostics Market Forecast
10.4.3 UK Viral Molecular Diagnostics Market Forecast
10.4.4 Italy Viral Molecular Diagnostics Market Forecast
10.4.5 Russia Viral Molecular Diagnostics Market Forecast
10.5 Middle East & Africa Viral Molecular Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Viral Molecular Diagnostics Market Forecast
10.5.2 South Africa Viral Molecular Diagnostics Market Forecast
10.5.3 Israel Viral Molecular Diagnostics Market Forecast
10.5.4 Turkey Viral Molecular Diagnostics Market Forecast
10.5.5 GCC Countries Viral Molecular Diagnostics Market Forecast
10.6 Global Viral Molecular Diagnostics Forecast by Type (2025-2030)
10.7 Global Viral Molecular Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboraories
11.1.1 Abbott Laboraories Company Information
11.1.2 Abbott Laboraories Viral Molecular Diagnostics Product Offered
11.1.3 Abbott Laboraories Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboraories Main Business Overview
11.1.5 Abbott Laboraories Latest Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Information
11.2.2 Bio-Rad Laboratories Viral Molecular Diagnostics Product Offered
11.2.3 Bio-Rad Laboratories Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bio-Rad Laboratories Main Business Overview
11.2.5 Bio-Rad Laboratories Latest Developments
11.3 Becton, Dickinson
11.3.1 Becton, Dickinson Company Information
11.3.2 Becton, Dickinson Viral Molecular Diagnostics Product Offered
11.3.3 Becton, Dickinson Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Becton, Dickinson Main Business Overview
11.3.5 Becton, Dickinson Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Viral Molecular Diagnostics Product Offered
11.4.3 Roche Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Gen-Probe
11.5.1 Gen-Probe Company Information
11.5.2 Gen-Probe Viral Molecular Diagnostics Product Offered
11.5.3 Gen-Probe Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Gen-Probe Main Business Overview
11.5.5 Gen-Probe Latest Developments
11.6 Qiagen
11.6.1 Qiagen Company Information
11.6.2 Qiagen Viral Molecular Diagnostics Product Offered
11.6.3 Qiagen Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Qiagen Main Business Overview
11.6.5 Qiagen Latest Developments
11.7 Olympus
11.7.1 Olympus Company Information
11.7.2 Olympus Viral Molecular Diagnostics Product Offered
11.7.3 Olympus Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Olympus Main Business Overview
11.7.5 Olympus Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific Viral Molecular Diagnostics Product Offered
11.8.3 Thermo Fisher Scientific Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Viral Molecular Diagnostics Market Size 2019-2030
2.1.2 Viral Molecular Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Viral Molecular Diagnostics Segment by Type
2.2.1 Hepatitis B Virus (HBV)
2.2.2 Hepatitis C Virus (HCV)
2.2.3 Human Immunodeficiency Virus (HIV)
2.2.4 Human Papillomavirus (HPV)
2.3 Viral Molecular Diagnostics Market Size by Type
2.3.1 Viral Molecular Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Viral Molecular Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Academics Institutions
2.4.3 Laboratories
2.4.4 Others
2.5 Viral Molecular Diagnostics Market Size by Application
2.5.1 Viral Molecular Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
3 VIRAL MOLECULAR DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Viral Molecular Diagnostics Market Size Market Share by Players
3.1.1 Global Viral Molecular Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Viral Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Viral Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VIRAL MOLECULAR DIAGNOSTICS BY REGIONS
4.1 Viral Molecular Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Viral Molecular Diagnostics Market Size Growth (2019-2024)
4.3 APAC Viral Molecular Diagnostics Market Size Growth (2019-2024)
4.4 Europe Viral Molecular Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Viral Molecular Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Viral Molecular Diagnostics Market Size by Country (2019-2024)
5.2 Americas Viral Molecular Diagnostics Market Size by Type (2019-2024)
5.3 Americas Viral Molecular Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Molecular Diagnostics Market Size by Region (2019-2024)
6.2 APAC Viral Molecular Diagnostics Market Size by Type (2019-2024)
6.3 APAC Viral Molecular Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Viral Molecular Diagnostics by Country (2019-2024)
7.2 Europe Viral Molecular Diagnostics Market Size by Type (2019-2024)
7.3 Europe Viral Molecular Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Viral Molecular Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Viral Molecular Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Viral Molecular Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VIRAL MOLECULAR DIAGNOSTICS MARKET FORECAST
10.1 Global Viral Molecular Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Viral Molecular Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Viral Molecular Diagnostics Forecast
10.1.3 APAC Viral Molecular Diagnostics Forecast
10.1.4 Europe Viral Molecular Diagnostics Forecast
10.1.5 Middle East & Africa Viral Molecular Diagnostics Forecast
10.2 Americas Viral Molecular Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Viral Molecular Diagnostics Market Forecast
10.2.2 Canada Viral Molecular Diagnostics Market Forecast
10.2.3 Mexico Viral Molecular Diagnostics Market Forecast
10.2.4 Brazil Viral Molecular Diagnostics Market Forecast
10.3 APAC Viral Molecular Diagnostics Forecast by Region (2025-2030)
10.3.1 China Viral Molecular Diagnostics Market Forecast
10.3.2 Japan Viral Molecular Diagnostics Market Forecast
10.3.3 Korea Viral Molecular Diagnostics Market Forecast
10.3.4 Southeast Asia Viral Molecular Diagnostics Market Forecast
10.3.5 India Viral Molecular Diagnostics Market Forecast
10.3.6 Australia Viral Molecular Diagnostics Market Forecast
10.4 Europe Viral Molecular Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Viral Molecular Diagnostics Market Forecast
10.4.2 France Viral Molecular Diagnostics Market Forecast
10.4.3 UK Viral Molecular Diagnostics Market Forecast
10.4.4 Italy Viral Molecular Diagnostics Market Forecast
10.4.5 Russia Viral Molecular Diagnostics Market Forecast
10.5 Middle East & Africa Viral Molecular Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Viral Molecular Diagnostics Market Forecast
10.5.2 South Africa Viral Molecular Diagnostics Market Forecast
10.5.3 Israel Viral Molecular Diagnostics Market Forecast
10.5.4 Turkey Viral Molecular Diagnostics Market Forecast
10.5.5 GCC Countries Viral Molecular Diagnostics Market Forecast
10.6 Global Viral Molecular Diagnostics Forecast by Type (2025-2030)
10.7 Global Viral Molecular Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboraories
11.1.1 Abbott Laboraories Company Information
11.1.2 Abbott Laboraories Viral Molecular Diagnostics Product Offered
11.1.3 Abbott Laboraories Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboraories Main Business Overview
11.1.5 Abbott Laboraories Latest Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Information
11.2.2 Bio-Rad Laboratories Viral Molecular Diagnostics Product Offered
11.2.3 Bio-Rad Laboratories Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bio-Rad Laboratories Main Business Overview
11.2.5 Bio-Rad Laboratories Latest Developments
11.3 Becton, Dickinson
11.3.1 Becton, Dickinson Company Information
11.3.2 Becton, Dickinson Viral Molecular Diagnostics Product Offered
11.3.3 Becton, Dickinson Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Becton, Dickinson Main Business Overview
11.3.5 Becton, Dickinson Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Viral Molecular Diagnostics Product Offered
11.4.3 Roche Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Gen-Probe
11.5.1 Gen-Probe Company Information
11.5.2 Gen-Probe Viral Molecular Diagnostics Product Offered
11.5.3 Gen-Probe Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Gen-Probe Main Business Overview
11.5.5 Gen-Probe Latest Developments
11.6 Qiagen
11.6.1 Qiagen Company Information
11.6.2 Qiagen Viral Molecular Diagnostics Product Offered
11.6.3 Qiagen Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Qiagen Main Business Overview
11.6.5 Qiagen Latest Developments
11.7 Olympus
11.7.1 Olympus Company Information
11.7.2 Olympus Viral Molecular Diagnostics Product Offered
11.7.3 Olympus Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Olympus Main Business Overview
11.7.5 Olympus Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific Viral Molecular Diagnostics Product Offered
11.8.3 Thermo Fisher Scientific Viral Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Viral Molecular Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Hepatitis B Virus (HBV)
Table 3. Major Players of Hepatitis C Virus (HCV)
Table 4. Major Players of Human Immunodeficiency Virus (HIV)
Table 5. Major Players of Human Papillomavirus (HPV)
Table 6. Viral Molecular Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Viral Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 9. Viral Molecular Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Viral Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 12. Global Viral Molecular Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Viral Molecular Diagnostics Revenue Market Share by Player (2019-2024)
Table 14. Viral Molecular Diagnostics Key Players Head office and Products Offered
Table 15. Viral Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Viral Molecular Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Viral Molecular Diagnostics Market Size Market Share by Regions (2019-2024)
Table 20. Global Viral Molecular Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Viral Molecular Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Viral Molecular Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Viral Molecular Diagnostics Market Size Market Share by Country (2019-2024)
Table 24. Americas Viral Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 26. Americas Viral Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 28. APAC Viral Molecular Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Viral Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Table 30. APAC Viral Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 32. APAC Viral Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 34. Europe Viral Molecular Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Viral Molecular Diagnostics Market Size Market Share by Country (2019-2024)
Table 36. Europe Viral Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 38. Europe Viral Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Viral Molecular Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Viral Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Viral Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Viral Molecular Diagnostics
Table 47. Key Market Challenges & Risks of Viral Molecular Diagnostics
Table 48. Key Industry Trends of Viral Molecular Diagnostics
Table 49. Global Viral Molecular Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Viral Molecular Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Viral Molecular Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Viral Molecular Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboraories Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 54. Abbott Laboraories Viral Molecular Diagnostics Product Offered
Table 55. Abbott Laboraories Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboraories Main Business
Table 57. Abbott Laboraories Latest Developments
Table 58. Bio-Rad Laboratories Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 59. Bio-Rad Laboratories Viral Molecular Diagnostics Product Offered
Table 60. Bio-Rad Laboratories Main Business
Table 61. Bio-Rad Laboratories Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Bio-Rad Laboratories Latest Developments
Table 63. Becton, Dickinson Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 64. Becton, Dickinson Viral Molecular Diagnostics Product Offered
Table 65. Becton, Dickinson Main Business
Table 66. Becton, Dickinson Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Becton, Dickinson Latest Developments
Table 68. Roche Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 69. Roche Viral Molecular Diagnostics Product Offered
Table 70. Roche Main Business
Table 71. Roche Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Roche Latest Developments
Table 73. Gen-Probe Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 74. Gen-Probe Viral Molecular Diagnostics Product Offered
Table 75. Gen-Probe Main Business
Table 76. Gen-Probe Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Gen-Probe Latest Developments
Table 78. Qiagen Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 79. Qiagen Viral Molecular Diagnostics Product Offered
Table 80. Qiagen Main Business
Table 81. Qiagen Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Qiagen Latest Developments
Table 83. Olympus Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 84. Olympus Viral Molecular Diagnostics Product Offered
Table 85. Olympus Main Business
Table 86. Olympus Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Olympus Latest Developments
Table 88. Thermo Fisher Scientific Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 89. Thermo Fisher Scientific Viral Molecular Diagnostics Product Offered
Table 90. Thermo Fisher Scientific Main Business
Table 91. Thermo Fisher Scientific Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Thermo Fisher Scientific Latest Developments
Table 1. Viral Molecular Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Hepatitis B Virus (HBV)
Table 3. Major Players of Hepatitis C Virus (HCV)
Table 4. Major Players of Human Immunodeficiency Virus (HIV)
Table 5. Major Players of Human Papillomavirus (HPV)
Table 6. Viral Molecular Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Viral Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 9. Viral Molecular Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Viral Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 12. Global Viral Molecular Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Viral Molecular Diagnostics Revenue Market Share by Player (2019-2024)
Table 14. Viral Molecular Diagnostics Key Players Head office and Products Offered
Table 15. Viral Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Viral Molecular Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Viral Molecular Diagnostics Market Size Market Share by Regions (2019-2024)
Table 20. Global Viral Molecular Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Viral Molecular Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Viral Molecular Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Viral Molecular Diagnostics Market Size Market Share by Country (2019-2024)
Table 24. Americas Viral Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 26. Americas Viral Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 28. APAC Viral Molecular Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Viral Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Table 30. APAC Viral Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 32. APAC Viral Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 34. Europe Viral Molecular Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Viral Molecular Diagnostics Market Size Market Share by Country (2019-2024)
Table 36. Europe Viral Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 38. Europe Viral Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Viral Molecular Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Viral Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Viral Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Viral Molecular Diagnostics
Table 47. Key Market Challenges & Risks of Viral Molecular Diagnostics
Table 48. Key Industry Trends of Viral Molecular Diagnostics
Table 49. Global Viral Molecular Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Viral Molecular Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Viral Molecular Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Viral Molecular Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboraories Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 54. Abbott Laboraories Viral Molecular Diagnostics Product Offered
Table 55. Abbott Laboraories Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboraories Main Business
Table 57. Abbott Laboraories Latest Developments
Table 58. Bio-Rad Laboratories Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 59. Bio-Rad Laboratories Viral Molecular Diagnostics Product Offered
Table 60. Bio-Rad Laboratories Main Business
Table 61. Bio-Rad Laboratories Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Bio-Rad Laboratories Latest Developments
Table 63. Becton, Dickinson Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 64. Becton, Dickinson Viral Molecular Diagnostics Product Offered
Table 65. Becton, Dickinson Main Business
Table 66. Becton, Dickinson Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Becton, Dickinson Latest Developments
Table 68. Roche Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 69. Roche Viral Molecular Diagnostics Product Offered
Table 70. Roche Main Business
Table 71. Roche Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Roche Latest Developments
Table 73. Gen-Probe Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 74. Gen-Probe Viral Molecular Diagnostics Product Offered
Table 75. Gen-Probe Main Business
Table 76. Gen-Probe Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Gen-Probe Latest Developments
Table 78. Qiagen Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 79. Qiagen Viral Molecular Diagnostics Product Offered
Table 80. Qiagen Main Business
Table 81. Qiagen Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Qiagen Latest Developments
Table 83. Olympus Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 84. Olympus Viral Molecular Diagnostics Product Offered
Table 85. Olympus Main Business
Table 86. Olympus Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Olympus Latest Developments
Table 88. Thermo Fisher Scientific Details, Company Type, Viral Molecular Diagnostics Area Served and Its Competitors
Table 89. Thermo Fisher Scientific Viral Molecular Diagnostics Product Offered
Table 90. Thermo Fisher Scientific Main Business
Table 91. Thermo Fisher Scientific Viral Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Thermo Fisher Scientific Latest Developments
LIST OF FIGURES
Figure 1. Viral Molecular Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Molecular Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Viral Molecular Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Viral Molecular Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Viral Molecular Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Viral Molecular Diagnostics Market Size Market Share by Type in 2023
Figure 10. Viral Molecular Diagnostics in Hospitals
Figure 11. Global Viral Molecular Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Viral Molecular Diagnostics in Academics Institutions
Figure 13. Global Viral Molecular Diagnostics Market: Academics Institutions (2019-2024) & ($ Millions)
Figure 14. Viral Molecular Diagnostics in Laboratories
Figure 15. Global Viral Molecular Diagnostics Market: Laboratories (2019-2024) & ($ Millions)
Figure 16. Viral Molecular Diagnostics in Others
Figure 17. Global Viral Molecular Diagnostics Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Viral Molecular Diagnostics Market Size Market Share by Application in 2023
Figure 19. Global Viral Molecular Diagnostics Revenue Market Share by Player in 2023
Figure 20. Global Viral Molecular Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Viral Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. APAC Viral Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Europe Viral Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Viral Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 25. Americas Viral Molecular Diagnostics Value Market Share by Country in 2023
Figure 26. United States Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Viral Molecular Diagnostics Market Size Market Share by Region in 2023
Figure 31. APAC Viral Molecular Diagnostics Market Size Market Share by Type in 2023
Figure 32. APAC Viral Molecular Diagnostics Market Size Market Share by Application in 2023
Figure 33. China Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Viral Molecular Diagnostics Market Size Market Share by Country in 2023
Figure 40. Europe Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Figure 41. Europe Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Figure 42. Germany Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. APAC Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. Europe Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. United States Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Canada Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. China Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Japan Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. Korea Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. India Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. Australia Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. Germany Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. France Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. UK Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Italy Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Russia Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. Spain Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. Israel Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 80. Global Viral Molecular Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Viral Molecular Diagnostics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Viral Molecular Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Molecular Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Viral Molecular Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Viral Molecular Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Viral Molecular Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Viral Molecular Diagnostics Market Size Market Share by Type in 2023
Figure 10. Viral Molecular Diagnostics in Hospitals
Figure 11. Global Viral Molecular Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Viral Molecular Diagnostics in Academics Institutions
Figure 13. Global Viral Molecular Diagnostics Market: Academics Institutions (2019-2024) & ($ Millions)
Figure 14. Viral Molecular Diagnostics in Laboratories
Figure 15. Global Viral Molecular Diagnostics Market: Laboratories (2019-2024) & ($ Millions)
Figure 16. Viral Molecular Diagnostics in Others
Figure 17. Global Viral Molecular Diagnostics Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Viral Molecular Diagnostics Market Size Market Share by Application in 2023
Figure 19. Global Viral Molecular Diagnostics Revenue Market Share by Player in 2023
Figure 20. Global Viral Molecular Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Viral Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. APAC Viral Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Europe Viral Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Viral Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 25. Americas Viral Molecular Diagnostics Value Market Share by Country in 2023
Figure 26. United States Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Viral Molecular Diagnostics Market Size Market Share by Region in 2023
Figure 31. APAC Viral Molecular Diagnostics Market Size Market Share by Type in 2023
Figure 32. APAC Viral Molecular Diagnostics Market Size Market Share by Application in 2023
Figure 33. China Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Viral Molecular Diagnostics Market Size Market Share by Country in 2023
Figure 40. Europe Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Figure 41. Europe Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Figure 42. Germany Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Viral Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Viral Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. APAC Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. Europe Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. United States Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Canada Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. China Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Japan Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. Korea Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. India Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. Australia Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. Germany Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. France Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. UK Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Italy Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Russia Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. Spain Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. Israel Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Viral Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 80. Global Viral Molecular Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Viral Molecular Diagnostics Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Knee Orthosis (KO) Market Growth 2023-2029
US$ 3,660.00
March 2023
109 pages
Global Positron Emission Tomography Scanners Market Growth 2024-2030
US$ 3,660.00
November 2024
113 pages
Global Dry X-ray Film Market Growth 2023-2029
US$ 3,660.00
March 2023
118 pages
Global Casimersen Market Growth 2024-2030
US$ 3,660.00
March 2024
80 pages
